Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Vulvar Neoplasms × lenvatinib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 99 Cholangiocarcinoma 22 Carcinoma, Renal Cell 16 Liver Neoplasms 10 Biliary Tract Neoplasms 9 Stomach Neoplasms 8 Endometrial Neoplasms 7 Breast Neoplasms 7 Thyroid Neoplasms 6 Neoplasms 6 Recurrence 5 Uterine Cervical Neoplasms 4 Melanoma 4 Thyroid Cancer, Papillary 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Neuroendocrine Tumors 3 Neoplasm Metastasis 3 Cirrhosis, Familial, with Pulmonary Hypertension 3 Advanced Biliary Tract Cancer 3 Adenocarcinoma, Follicular 3 Adenocarcinoma 3 Uveal Melanoma 2 Thyroid Carcinoma, Anaplastic 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Paraganglioma, Extra-Adrenal 2 Mesothelioma, Malignant 2 Liver Diseases 2 Kidney Neoplasms 2

Interventions

Methods 6 Surveys and Questionnaires 4 Radiotherapy 4 Cisplatin 4 pembrolizumab 3 Sentinel Lymph Node Biopsy 3 Radiosurgery 3 Palliative Care 3 Indocyanine Green 3 Early Intervention, Educational 3 Brachytherapy 3 Bleomycin 3 tremelimumab 2 durvalumab 2 Surgical Procedures, Operative 2 Radiation 2 Imiquimod 2 Gemcitabine 2 Electrochemotherapy 2 Drug Therapy 2 Dehydroepiandrosterone 2 Carboplatin 2 Biopsy 2 Bevacizumab 2 Behavior Therapy 2 zimberelimab 1 tivozanib 1 sapropterin 1 nanocis 1 liposomal doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07290894 2025-12-18

MITO VULVA-01

National Cancer Institute, Naples

Phase 2 Not yet recruiting

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡